West Pharmaceutical Services Inc. Appoints Robert McMahon as New Chief Financial Officer, Effective August 2025
West Pharmaceutical Services Inc. has announced the appointment of Robert McMahon as the new Chief Financial Officer, effective August 4, 2025. McMahon will replace Bernard Birkett, who is retiring but will remain as Senior Advisor to the CEO until the end of the year to facilitate a smooth transition. Prior to this, McMahon served as the CFO of Agilent Technologies Inc.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. West Pharmaceutical Services Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: NE33491) on July 21, 2025, and is solely responsible for the information contained therein.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。